Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy

Journal of Diabetes and its Complications

Volumn 22, Issue 3, 2008, Pages 186-190

  Eroglu, Zuhal ^a   Cetinkalp, S ^b   Erdogan, Mehmet ^b   Kosova, B ^a   Karadeniz, Muammer ^b   Kutukculer, A ^a   Gunduz, C ^a   Tetik, A ^a   Topcuoglu, N ^a   Ozgen, A G ^b   Tuzun, M ^b  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Diabetic nephropathy; I D polymorphism; M235T polymorphism

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TURKEY (REPUBLIC);

AGED; ALBUMINURIA; AMINO ACID SUBSTITUTION; ANGIOTENSINOGEN; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE DELETION; TURKEY;

EID: 42149155072     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.12.004     Document Type: Article

References (42)

1. Bedir A., Arik N., Adam B., Kilinc K., Gumus T., and Guner E. Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension. American Journal of Hypertension 12 (1999) 1038-1043
2. Buraczyska M., Ksiazek P., Lopatynski J., Spasiewicz D., Nowicka T., and Ksiazek A. Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes. Polskie Archiwum Medycyny Wewnetrznej 108 2 (2002) 725-730
3. Burden A.C., McNally P.G., Feehally J., and Walls J. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabetic Medicine 9 (1992) 641-645
4. Chowdhury T.A., Dronsfield M.J., Kumar S., Gough S.L.C., Gibson S.P., Khatoon A., MacDonald F., Rowe B.R., Dunger D.B., Dean J.D., Davies S.J., Webber J., Smith P.R., Mackin P., Marshall S.M., Adu D., Morris P.J.M., Todd J.A., Barnett A.H., Boulton A.J.M., and Bain S.C. Examination of two genetic polymorphisms within the renin-angiotensin system: No evidence for an association with nephropathy in IDDM. Diabetologia 39 (1996) 1108-1114
5. Collins V.R., Dowse G.K., Finch C.F., Zimmet P.Z., and Linnanae A.W. Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes 38 (1989) 1602-1610
6. Cowie C.C., Port F.K., Wolfe R.A., Savage P.J., Moll P.P., and Hawthorne V.M. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. New England Journal of Medicine 321 (1989) 1074-1079
7. Donnelly R., Emslie-Smith A.M., Gardner I.D., and Morris A.D. ABC of arterial and venous disease: Vascular complications of diabetes. BMJ 15 (2000) 1062-1066
8. Doria A., Onuma T., Gearin G., Freire M.B.S., Warram J.H., and Krolewski A.S. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 27 (1996) 1134-1139
9. Ergen H.A., Hatemi H., Agachan B., Camlica H., and Isbir T. Angiotensin-1 converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Experimental and Molecular Medicine 36 4 (2004) 345-350
10. Fogarty D.G., Harron J.C., Hughes A.E., Nevin N.C., Doherty C.C., and Maxwell A.P. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45 (1996) 1204-1208
11. Fradin S., Goulet-Salmon B., Chantepie M., Grandhomme F., Morello R., Jauzac P., and Reznik Y. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes and Metabolism 28 1 (2002) 27-32
12. Freire M.B.S., Ji L., Onuma T., Orban T., Warram J.H., and Krolewski A.S. Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 31 (1998) 896-899
13. Fujisawa T., Ikegami H., Kawaguchi Y., Hamada Y., Ueda H., Shintani M., Fukuda M., and Ogihara T. Meta analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41 (1998) 47-53
14. Grzeszczak W., Zychma M.J., Lacka B., and Zukowska-Szczechowska E. Angiotensin I-converting enzyme gene polymorphisms: Relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. Journal of the American Society of Nephrology 9 9 (1998) 1664-1669
15. Gutierrez C., Vendrell J., Pastor R., et al. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in Caucasian Mediterranean population. Metabolism 46 (1997) 976-980
16. Haffner S.M., Mitchell B.D., Pugh J.A., et al. Proteinuria in Mexican-Americans and non-Hispanic whites with NIDDM. Diabetes Care 12 (1986) 530-536
17. Hopkins P.N., Lifton R.P., Hollenberg N.K., et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. Journal of Hypertension 14 (1996) 199-207
18. Inoue I., Nakajima T., Williams C.S., et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. Journal of Clinical Investigation 99 (1997) 1786-1797
19. Jeffers B.W., Estacio R.O., Raynolds M.V., and Schrier R.W. Angiotensin converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney International 52 (1997) 473-477
20. Jeunemaitre X., Inoue I., Williams C., et al. Haplotypes of angiotensinogen in essential hypertension. American Journal of Human Genetics 60 (1997) 1448-1460
21. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 71 (1992) 169-180
22. Liao L., Lei M., Han X., Chen H., and Fan C. Relationship between serum angiotensin I-converting enzyme activity and diabetic nephropathy in patients with type II diabetes. Hunan Yi Ke Da Xue Xue Bao 24 (1999) 263-266
23. Zychma M.J., Zukowska-Szczechowska E., Lacka B.I., and Grzeszczak W. Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes. Nephrology, Dialysis, Transplantation 15 (2000) 1965-1970
24. Marre M., Bernadet P., Gallois Y., Savagner F., Guyene T.T., Hallab M., Cambien F., Passa P., and Alhenc-Gelas F. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43 3 (1994) 384-388
25. Marre M., Jeunemaitre X., Gallois Y., Rodier M., Chatellier G., Sert C., Dusselier L., Kahal Z., Chaillous L., Halimi S., Muller A., Sackmann H., Bauduceau B., Bled F., Passa P., and Alhenc-Gelas F. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. Journal of Clinical Investigation 1;99 7 (1997) 1585-1595
26. McCance D.R., Hanson R.L., Pettitt D.J., et al. Diabetic nephropathy: A risk factor for diabetes mellitus in offspring. Diabetologia 38 (1995) 221-226
27. Nosadini R., Brocco E., Faronato P., et al. Clustering of abnormalities in albumin excretion rate (AER) in families of type 2 diabetic patients. Diabetologia 39 Suppl 1 (1996) A298
28. Parving H.H. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment. Diabetologia 41 (1998) 745-759
29. Pettitt D.J., Saad M.F., Bennet P.H., Nelson R.G., and Knowler W.C. Familiar predisposition to renal disease in two generation of Pima Indians with type 2 (NIDDM) diabetes mellitus. Diabetologia 39 (1990) 438-443
30. Quinn M., Angelico M.C., Warram J.H., and Krolewski A.S. Familiar factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39 (1996) 940-945
31. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation 86 4 (1990) 1343-1346
32. Ringel J., Beige J., Kunz R., Distler A., and Sharma A.M. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 40 (1997) 193-199
33. Rogus J.J., Moczulski D., Freire M.B.S., Yang Y., Warram J.H., and Krolewski A.S. Diabetic nephropathy is associated with AGT polymorphism T235. Results of a family-based study. Hypertension 31 (1998) 627-631
34. Schmidt S., Giessel R., Bergis K.H., et al., and the Diabetic Nephropathy Study Group. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrology, Dialysis, Transplantation 11 (1996) 1755-1761
35. Schmidt S., and Ritz E. Angiotensin-1 converting enzyme gene polymorphism and diabetic nephropathy in type 2 diabetes. Nephrology, Dialysis, Transplantation 12 (1997) 37-41
36. Seaquist E.R., Goetz F.C., Ricks S., and Barbosa J. Familiar clustering of diabetic nephropathy. New England Journal of Medicine 320 (1989) 1161-1165
37. Strojek K., Grzeszczak W., Morawin E., et al. Nephropathy of type II diabetes-Evidence for hereditary factors?. Kidney International 51 (1997) 1602-1607
38. Tarnow L., Cambien F., Rossing P., et al. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 45 (1996) 367-369
39. Tarnow L., Cambien F., Rossing P., Nielsen F.S., Hansen B.V., Ricard S., Poirier O., and Parving H.-H. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 45 (1996) 367-369
40. Wang J., Zhu X., Yang L., Liu Y., Zhou W., and Li H. Relationship between angiotensinogen gene M235T variant with diabetic nephropathy in Chinese NIDDM. Chinese Medical Journal (Engl) 112 9 (1999) 797-800
41. Wong T.Y., Chan J.C., Poon E., and Li P.K. Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. American Journal of Kidney Diseases 33 6 (1999) 1064-1070
42. Wu S., Xiang K., Zheng T., Sun D., Weng Q., Zhao H., and Li J. Relationship between the renin-angiotensin system genes and diabetic nephropathy in the Chinese. Chinese Medical Journal 113 5 (2000) 437-441